More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene
Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds
ASTRO Issues Statement On APBI For Breast Cancer
Denosumab Demonstrates Superiority Over Zometa For Bone Metastases
Lymphedema Education Helps Reduce Symptoms, Study Finds
Exercise May Help Combat Leukemia Patients’ Fatigue
Cranial Radiation Eliminated With Personalized Chemo
Young Early-Stage Patients Can Preserve Fertility
Limb-Sparing Surgery May Not Offer Better Quality of Life
AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows
Budesonide Not Beneficial For Diarrhea In Melanoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
